Comparison of continuous and twice-daily infusions of cyclosporine A for graft-versus-host-disease prophylaxis in pediatric hematopoietic stem cell transplantation-Reference-Cited by-同舟云学术

Comparison of continuous and twice-daily infusions of cyclosporine A for graft-versus-host-disease prophylaxis in pediatric hematopoietic stem cell transplantation

Published:2014-10-12 Issue:2 Volume:62 Page:291-298
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Umeda Katsutsugu¹,Adachi Souichi²,Tanaka Shiro³,Ogawa Atsushi⁴,Hatakeyama Naoki⁵,Kudo Kazuko⁶,Sakata Naoki⁷,Igarashi Shunji⁸,Ohshima Kumi⁹,Hyakuna Nobuyuki¹⁰,Chin Motoaki¹¹,Goto Hiroaki¹²,Takahashi Yoshiyuki¹³,Azuma Eiichi¹⁴,Koh Katsuyoshi¹⁵,Sawada Akihisa¹⁶,Kato Koji¹⁷,Inoue Masami¹⁶,Atsuta Yoshiko¹⁸¹⁹,Takami Akiyoshi²⁰,Murata Makoto²¹,

Affiliation:

1. Department of Pediatrics; Graduate School of Medicine; Kyoto University; Kyoto Japan

2. Human Health Sciences; Graduate School of Medicine; Kyoto University; Kyoto Japan

3. Department of Pharmacoepidemiology; Graduate School of Medicine and Public Health; Kyoto University; Kyoto Japan

4. Department of Pediatrics; Niigata Cancer Center Hospital; Niigata Japan

5. Department of Pediatrics; Sapporo Medical University Hospital; Sapporo Japan

6. Division of Hematology and Oncology; Shizuoka Children's Hospital; Shizuoka Japan

7. Department of Pediatrics; Kinki University; Faculty of Medicine; Osaka Japan

8. Division of Pediatrics; Japanese Red Cross Narita Hospital; Narita Japan

9. Division of Hematology; Saitama Medical Center; Jichi Medical University; Saitama Japan

10. Center of Bone Marrow Transplantation; Ryukyu University Hospital; Okinawa Japan

11. Department of Pediatrics and Child Health; Nihon University Itabashi Hospital; Tokyo Japan

12. Division of Hemato-oncology/Regeneration Medicine; Kanagawa Children's Medical Center; Kanagawa Japan

13. Department of Pediatrics; Nagoya University Graduate School of Medicine; Nagoya Japan

14. Department of Pediatrics and Cell Transplantation; Mie University Graduate School of Medicine; Mie Japan

15. Department of Hematology/Oncology; Saitama Children's Medical Center; Saitama Japan

16. Department of Hematology/Oncology; Osaka Medical Center and Research Institute for Maternal and Child Health; Osaka Japan

17. Department of Hematology and Oncology; Children's Medical Center; Japanese Red Cross Nagoya First Hospital; Nagoya Japan

18. Japanese Data Center for Hematopoietic Cell Transplantation; Nagoya Japan

19. Nagoya University Graduate School of Medicine; Nagoya Japan

20. Department of Hematology and Oncology; Kanazawa University Hospital; Kanazawa Japan

21. Department of Hematology and Oncology; Nagoya University Graduate School of Medicine; Nagoya Japan

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Reference19 articles.

1. Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukaemia: Long-term follow up of a controlled trial;Storb;Blood,1989

2. A survey of the prophylaxis and treatment of acute GVHD in Europe: A report of the European group for blood and marrow transplantation (EBMT);Ruutu;Bone Marrow Transplant,1997

3. The temporal profile of calcineurin inhibition by cyclosporine in vivo;Halloran;Transplantation,1999

4. Stimulated response of peripheral lymphocytes may distinguish cyclosporine effect in renal transplant recipients receiving a cyclosporine + rapamycin regimen;Sindhi;Transplantation,2000

5. Pharmacodynamic monitoring of calcineurin inhibition therapy: Principles, performance, and perspectives;van Rossum;Ther Drug Monit,2010

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of the effect of different methods of cyclosporine infusion on transplant-related outcomes in allogeneic transplant recipients;Journal of Oncology Pharmacy Practice;2021-02-24

2. Higher plasma bilirubin predicts veno-occlusive disease in early childhood undergoing hematopoietic stem cell transplantation with cyclosporine;World Journal of Transplantation;2016

3. In vitro study of cyclosporine A 0.05 % on primary and recurrent pterygium fibroblasts;International Ophthalmology;2015-08-11

4. Prophylactic and therapeutic treatment of graft-versus-host disease in Japan;International Journal of Hematology;2015-04-12

5. Drugs that Act on the Immune System;Side Effects of Drugs Annual;2015